In summary, we observed that IDO1 transcript expression varies substantially between and within cancer types, with uterine and ovarian cancers having the highest proportion of high expressors and hepatobiliary cancers having no high expressors, albeit with a limited number of patients tested. The gene discussed is IDO1; the disease is cancer.